Pharma

Your Article Summary

See Latest Articles

Multaq (dronedarone) for Atrial Fibrillation or Atrial Flutter Now Available in the United States
Sanofi-aventis, 07/29/09

Sanofi–aventis announced that Multaq 400 mg Tablets is now available in pharmacies in the United States. Multaq is an anti–arrhythmic drug indicated to reduce the risk of cardiovascular hospitalization in patients with paroxysmal or persistent atrial fibrillation or atrial flutter, with a recent episode of AF/AFL and associated cardiovascular risk factors, who are in sinus rhythm or who will be cardioverted.

Today in Medical Devices/Products...keeping you current

Receive free subspecialty "5-minute updates" via email

Chugai Revises Corporate Advertisement for First Time in Four Years
Chugai Pharmaceutical Co., 11/25/09

Huntington Hill Installs Toshiba Aquilion Premium CT
Imaging Economics, 11/25/09

Baytubes carbon nanotubes in marine coatings help reduce frictional resistance
BayNews International, 11/24/09

 See all of Medical Devices/Products